Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: Experiences from 3-year follow-up
European Journal of Clinical Microbiology & Infectious Diseases Apr 26, 2018
Ma Y, et al. - In view of no study regarding the role of metformin (MET) on treatment effect of diabetic tuberculosis (TB) patients in China, a retrospective study was conducted in China to investigate if MET exhibited more efficacy in combination with anti-TB regimens for diabetic TB patients. Data revealed an improvement in the success rate of anti-TB treatment with the use of MET as a combination drug with existing regimen. A reduction in the relapse rate among TB patients with DM was also noted with the combination treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries